Endo Other Stockholder Equity vs Other Current Liab Analysis

0Y5F Stock

629.53 9.30 1.50%

Endo International financial indicator trend analysis is much more than just examining Endo International PLC latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Endo International PLC is a good investment. Please check the relationship between Endo International Other Stockholder Equity and its Other Current Liab accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Endo International PLC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Other Stockholder Equity vs Other Current Liab

Other Stockholder Equity vs Other Current Liab Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Endo International PLC Other Stockholder Equity account and Other Current Liab. At this time, the significance of the direction appears to have weak contrarian relationship.

The correlation between Endo International's Other Stockholder Equity and Other Current Liab is -0.04. Overlapping area represents the amount of variation of Other Stockholder Equity that can explain the historical movement of Other Current Liab in the same time period over historical financial statements of Endo International PLC, assuming nothing else is changed. The correlation between historical values of Endo International's Other Stockholder Equity and Other Current Liab is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Other Stockholder Equity of Endo International PLC are associated (or correlated) with its Other Current Liab. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Other Current Liab has no effect on the direction of Other Stockholder Equity i.e., Endo International's Other Stockholder Equity and Other Current Liab go up and down completely randomly.

Correlation Coefficient

-0.04

Relationship Direction	Negative
Relationship Strength	Insignificant

View All Relationships

Other Stockholder Equity

Other Current Liab

Most indicators from Endo International's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Endo International PLC current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Endo International PLC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Selling General Administrative is likely to gain to about 495.1 M in 2024, whereas Tax Provision is likely to drop (174.3 M) in 2024.

	2021	2022	2023	2024 (projected)
Gross Profit	1.8B	1.3B	1.1B	1.1B
Total Revenue	3.0B	2.3B	2.0B	2.3B

Gross Profit Total Revenue

Endo International fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Cash And Short Term Investments	Net Receivables	Good Will	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Intangible Assets	Common Stock	Short Term Investments	Short Long Term Debt Total
Total Assets		0.85	0.79	0.69	0.74	0.02	0.14	-0.32	-0.26	0.98	-0.82	0.4	-0.26	0.64	0.95	0.25	0.22	0.91	0.31	0.37	0.61	0.48	0.96	-0.47	-0.36	0.41
Other Current Liab	0.85		0.99	0.88	0.35	-0.15	0.53	0.06	-0.51	0.76	-0.85	0.43	-0.51	0.82	0.8	-0.14	-0.19	0.84	0.67	-0.04	0.22	0.71	0.76	-0.17	0.1	0.64
Total Current Liabilities	0.79	0.99		0.92	0.23	-0.14	0.63	0.19	-0.55	0.69	-0.81	0.41	-0.55	0.84	0.75	-0.26	-0.31	0.81	0.71	-0.16	0.09	0.73	0.7	-0.05	0.22	0.7
Total Stockholder Equity	0.69	0.88	0.92		0.11	-0.03	0.79	0.36	-0.55	0.61	-0.73	0.43	-0.55	0.76	0.69	-0.43	-0.47	0.79	0.57	-0.32	-0.13	0.56	0.63	0.21	0.35	0.82
Property Plant And Equipment Net	0.74	0.35	0.23	0.11		0.07	-0.44	-0.71	0.11	0.81	-0.5	0.4	0.11	0.18	0.7	0.68	0.71	0.59	-0.23	0.75	0.88	-0.02	0.8	-0.7	-0.79	-0.11
Net Debt	0.02	-0.15	-0.14	-0.03	0.07		-0.22	-0.3	0.72	0.03	0.48	-0.13	0.72	-0.17	0.18	0.35	0.27	-0.17	-0.29	0.34	0.12	0.03	-0.11	-0.25	-0.3	0.32
Retained Earnings	0.14	0.53	0.63	0.79	-0.44	-0.22		0.83	-0.72	0.05	-0.4	0.21	-0.72	0.6	0.11	-0.89	-0.9	0.41	0.63	-0.84	-0.68	0.43	0.11	0.72	0.84	0.68
Accounts Payable	-0.32	0.06	0.19	0.36	-0.71	-0.3	0.83		-0.62	-0.39	-0.02	-0.04	-0.62	0.29	-0.36	-0.96	-0.94	-0.02	0.43	-0.96	-0.88	0.15	-0.31	0.87	0.94	0.31
Cash	-0.26	-0.51	-0.55	-0.55	0.11	0.72	-0.72	-0.62		-0.19	0.64	-0.28	1.0	-0.67	-0.09	0.68	0.6	-0.57	-0.65	0.63	0.31	-0.35	-0.31	-0.47	-0.61	-0.15
Non Current Assets Total	0.98	0.76	0.69	0.61	0.81	0.03	0.05	-0.39	-0.19		-0.81	0.39	-0.19	0.5	0.96	0.33	0.32	0.88	0.12	0.45	0.66	0.28	0.99	-0.47	-0.47	0.35
Non Currrent Assets Other	-0.82	-0.85	-0.81	-0.73	-0.5	0.48	-0.4	-0.02	0.64	-0.81		-0.44	0.64	-0.62	-0.75	0.11	0.08	-0.87	-0.39	-0.01	-0.32	-0.32	-0.87	0.09	0.03	-0.38
Other Assets	0.4	0.43	0.41	0.43	0.4	-0.13	0.21	-0.04	-0.28	0.39	-0.44		-0.28	0.53	0.34	0.04	-0.02	0.46	0.09	0.06	0.12	0.13	0.46	-0.08	-0.06	0.26
Cash And Short Term Investments	-0.26	-0.51	-0.55	-0.55	0.11	0.72	-0.72	-0.62	1.0	-0.19	0.64	-0.28		-0.67	-0.09	0.68	0.6	-0.57	-0.65	0.63	0.31	-0.35	-0.31	-0.47	-0.61	-0.15
Net Receivables	0.64	0.82	0.84	0.76	0.18	-0.17	0.6	0.29	-0.67	0.5	-0.62	0.53	-0.67		0.48	-0.32	-0.37	0.77	0.81	-0.27	0.01	0.81	0.54	0.0	0.33	0.43
Good Will	0.95	0.8	0.75	0.69	0.7	0.18	0.11	-0.36	-0.09	0.96	-0.75	0.34	-0.09	0.48		0.31	0.29	0.82	0.17	0.43	0.59	0.36	0.92	-0.46	-0.42	0.52
Common Stock Shares Outstanding	0.25	-0.14	-0.26	-0.43	0.68	0.35	-0.89	-0.96	0.68	0.33	0.11	0.04	0.68	-0.32	0.31		0.97	-0.07	-0.49	0.99	0.88	-0.2	0.25	-0.91	-0.97	-0.38
Non Current Liabilities Total	0.22	-0.19	-0.31	-0.47	0.71	0.27	-0.9	-0.94	0.6	0.32	0.08	-0.02	0.6	-0.37	0.29	0.97		-0.04	-0.53	0.97	0.89	-0.29	0.25	-0.85	-0.96	-0.47
Inventory	0.91	0.84	0.81	0.79	0.59	-0.17	0.41	-0.02	-0.57	0.88	-0.87	0.46	-0.57	0.77	0.82	-0.07	-0.04		0.43	0.05	0.35	0.46	0.92	-0.14	-0.06	0.39
Other Current Assets	0.31	0.67	0.71	0.57	-0.23	-0.29	0.63	0.43	-0.65	0.12	-0.39	0.09	-0.65	0.81	0.17	-0.49	-0.53	0.43		-0.46	-0.22	0.91	0.14	0.11	0.58	0.34
Other Stockholder Equity	0.37	-0.04	-0.16	-0.32	0.75	0.34	-0.84	-0.96	0.63	0.45	-0.01	0.06	0.63	-0.27	0.43	0.99	0.97	0.05	-0.46		0.92	-0.17	0.36	-0.92	-0.98	-0.31
Total Liab	0.61	0.22	0.09	-0.13	0.88	0.12	-0.68	-0.88	0.31	0.66	-0.32	0.12	0.31	0.01	0.59	0.88	0.89	0.35	-0.22	0.92		0.02	0.61	-0.91	-0.9	-0.29
Total Current Assets	0.48	0.71	0.73	0.56	-0.02	0.03	0.43	0.15	-0.35	0.28	-0.32	0.13	-0.35	0.81	0.36	-0.2	-0.29	0.46	0.91	-0.17	0.02		0.25	-0.18	0.3	0.4
Intangible Assets	0.96	0.76	0.7	0.63	0.8	-0.11	0.11	-0.31	-0.31	0.99	-0.87	0.46	-0.31	0.54	0.92	0.25	0.25	0.92	0.14	0.36	0.61	0.25		-0.38	-0.4	0.32
Common Stock	-0.47	-0.17	-0.05	0.21	-0.7	-0.25	0.72	0.87	-0.47	-0.47	0.09	-0.08	-0.47	0.0	-0.46	-0.91	-0.85	-0.14	0.11	-0.92	-0.91	-0.18	-0.38		0.84	0.27
Short Term Investments	-0.36	0.1	0.22	0.35	-0.79	-0.3	0.84	0.94	-0.61	-0.47	0.03	-0.06	-0.61	0.33	-0.42	-0.97	-0.96	-0.06	0.58	-0.98	-0.9	0.3	-0.4	0.84		0.34
Short Long Term Debt Total	0.41	0.64	0.7	0.82	-0.11	0.32	0.68	0.31	-0.15	0.35	-0.38	0.26	-0.15	0.43	0.52	-0.38	-0.47	0.39	0.34	-0.31	-0.29	0.4	0.32	0.27	0.34

Click cells to compare fundamentals

Endo International Account Relationship Matchups

Endo International fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	9.4B	9.3B	8.8B	5.8B	5.1B	7.8B
Other Current Liab	1.3B	1.1B	1.3B	577.6M	442.4M	420.3M
Total Current Liabilities	1.5B	1.3B	1.6B	689.6M	538.8M	511.9M
Total Stockholder Equity	(866.5M)	(647.9M)	(1.2B)	(4.2B)	(6.6B)	(6.3B)
Property Plant And Equipment Net	556.6M	495.5M	431.5M	466.4M	499.3M	544.1M
Net Debt	6.8B	7.0B	6.7B	(1.2B)	(939.1M)	(892.2M)
Retained Earnings	(9.6B)	(9.4B)	(10.0B)	(12.9B)	(15.4B)	(14.6B)
Accounts Payable	101.5M	94.4M	123.1M	109.0M	94.7M	129.8M
Cash	1.7B	1.4B	1.6B	1.2B	945.6M	1.0B
Non Current Assets Total	6.8B	6.9B	6.1B	3.7B	3.5B	5.6B
Non Currrent Assets Other	59.7M	53.2M	5.1M	38.1M	(1.4B)	(1.5B)
Other Assets	80.3M	55.1M	61.5M	129.8M	1.0	0.95
Cash And Short Term Investments	1.7B	1.4B	1.6B	1.2B	945.6M	1.0B
Net Receivables	515.5M	575.1M	602.0M	502.6M	396.8M	540.0M
Good Will	3.6B	3.6B	3.2B	1.4B	1.2B	1.2B
Common Stock Shares Outstanding	226.1M	233.7M	232.8M	234.8M	235.2M	222.0M
Non Current Liabilities Total	8.8B	8.7B	8.4B	9.2B	11.2B	8.2B
Inventory	327.9M	352.3M	283.6M	274.5M	246.0M	309.4M
Other Current Assets	40.8M	100.9M	197.7M	135.4M	80.1M	76.1M
Other Stockholder Equity	8.9B	8.9B	9.0B	9.0B	9.0B	7.5B
Total Liab	10.3B	9.9B	10.0B	9.9B	11.7B	10.9B
Total Current Assets	2.6B	2.4B	2.7B	2.1B	1.7B	2.2B
Intangible Assets	2.6B	2.7B	2.4B	1.7B	1.5B	2.6B
Short Long Term Debt Total	8.5B	8.4B	8.3B	7.4M	6.5M	6.2M
Long Term Debt	8.2B	8.2B	8.4B	8.3B	9.5B	9.1B
Capital Surpluse	8.8B	8.9B	8.9B	8.9B	10.3B	9.7B
Property Plant Equipment	556.6M	495.5M	431.5M	466.4M	419.7M	416.3M
Other Liab	356.3M	315.0M	280.4M	1.2B	1.3B	1.4B
Net Tangible Assets	(7.0B)	(6.9B)	(6.8B)	(7.2B)	(8.3B)	(8.8B)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

ESRT	Empire State Realty
C	Citigroup
C	Citigroup

Additional Tools for Endo Stock Analysis

When running Endo International's price analysis, check to measure Endo International's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Endo International is operating at the current time. Most of Endo International's value examination focuses on studying past and present price action to predict the probability of Endo International's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Endo International's price. Additionally, you may evaluate how the addition of Endo International to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Endo Other Stockholder Equity vs Other Current Liab Analysis

Other Stockholder Equity vs Other Current Liab

Other Stockholder Equity vs Other Current Liab Correlation Analysis

Correlation Coefficient

Other Stockholder Equity

Other Current Liab

Endo International fundamental ratios Correlations

Endo International Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Endo International fundamental ratios Accounts

Also Currently Popular

Additional Tools for Endo Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash And Short Term Investments	+ 1.0	Cash
Total Current Liabilities	+ 0.99	Other Current Liab
Intangible Assets	+ 0.99	Non Current Assets Total
Other Stockholder Equity	+ 0.99	Common Stock Shares Outstanding
Non Current Assets Total	+ 0.98	Total Assets
Non Current Liabilities Total	+ 0.97	Common Stock Shares Outstanding

Short Term Investments	- 0.98	Other Stockholder Equity
Short Term Investments	- 0.97	Common Stock Shares Outstanding
Short Term Investments	- 0.96	Non Current Liabilities Total
Other Stockholder Equity	- 0.96	Accounts Payable
Common Stock Shares Outstanding	- 0.96	Accounts Payable
Non Current Liabilities Total	- 0.94	Accounts Payable